In conclusion, our findings suggest that while 3-NT levels are influenced by inflammation, as indicated by correlations with CRP and the SDAI, they do not appear to be strongly associated with disease characteristics, CV risk, or DMARD usage in RA patients. The gene discussed is CRP; the disease is rheumatoid arthritis.